$IHAI nice bounce on huge revenue news: Innovative
Post# of 27158
Posted On: 03/22/2016 10:38:38 AM
$IHAI nice bounce on huge revenue news: Innovative Holdings Alliance, Inc. Realizing Revenues With Announcement of Joint Venture Agreement With Healthmed, Inc. and HMIH, Inc.
http://finance.yahoo.com/news/innovative-hold...00520.html
ATLANTA, GA--(Marketwired - Mar 22, 2016) - Innovative Holdings Alliance, Inc. (Innovative) (OTC PINK: IHAI) is pleased to announce a Joint Venture Agreement with Healthmed, Inc. and its subsidiary HMIH, Inc.
This Agreement will allow Innovative to further our interests in the ever growing medicinal CBD markets. Through this Agreement, Innovative will now have the ability to work more closely with doctors, clinicians and additional organizations to monitor and collect information on patients and other individuals to further research and potentially accelerate therapeutic effects and values.
In an article from the June 24, 2015 edition published by the NIH (National Institutes of Health), leading experts claim, "CBD is one of more than 80 active cannabinoid chemicals in the marijuana plant. Unlike the main psychoactive cannabinoid in marijuana, tetrahydrocannabinol (THC), CBD does not produce euphoria or intoxication. Cannabinoids have their effect mainly by interacting with specific receptors on cells in the brain and body: the CB1 receptor, found on neurons and glial cells in various parts of the brain, and the CB2 receptor, found mainly in the body's immune system. The euphoric effects of THC are caused by its activation of CB1 receptors. CBD has a very low affinity for these receptors (100 fold less than THC) and when it binds it produces little to no effect. There is also growing evidence that CBD acts on other brain signaling systems, and that these actions may be important contributors to its therapeutic effects."
Innovative is already realizing revenues and anticipates revenues of $1,300,000.00 to $1,400,000.00 by this calendar year end.
"We are extremely enthusiastic about this new endeavor. I have known Chris for some time now and am extremely pleased to join forces with Innovative in this exciting and beneficial venture," stated Tracy Webster, CEO of Healthmed, Inc.
http://finance.yahoo.com/news/innovative-hold...00520.html
ATLANTA, GA--(Marketwired - Mar 22, 2016) - Innovative Holdings Alliance, Inc. (Innovative) (OTC PINK: IHAI) is pleased to announce a Joint Venture Agreement with Healthmed, Inc. and its subsidiary HMIH, Inc.
This Agreement will allow Innovative to further our interests in the ever growing medicinal CBD markets. Through this Agreement, Innovative will now have the ability to work more closely with doctors, clinicians and additional organizations to monitor and collect information on patients and other individuals to further research and potentially accelerate therapeutic effects and values.
In an article from the June 24, 2015 edition published by the NIH (National Institutes of Health), leading experts claim, "CBD is one of more than 80 active cannabinoid chemicals in the marijuana plant. Unlike the main psychoactive cannabinoid in marijuana, tetrahydrocannabinol (THC), CBD does not produce euphoria or intoxication. Cannabinoids have their effect mainly by interacting with specific receptors on cells in the brain and body: the CB1 receptor, found on neurons and glial cells in various parts of the brain, and the CB2 receptor, found mainly in the body's immune system. The euphoric effects of THC are caused by its activation of CB1 receptors. CBD has a very low affinity for these receptors (100 fold less than THC) and when it binds it produces little to no effect. There is also growing evidence that CBD acts on other brain signaling systems, and that these actions may be important contributors to its therapeutic effects."
Innovative is already realizing revenues and anticipates revenues of $1,300,000.00 to $1,400,000.00 by this calendar year end.
"We are extremely enthusiastic about this new endeavor. I have known Chris for some time now and am extremely pleased to join forces with Innovative in this exciting and beneficial venture," stated Tracy Webster, CEO of Healthmed, Inc.
(0)
(0)